文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

使用MR-Linac自适应计划对中危前列腺癌进行SBRT局灶剂量强化:分次内器官变化的剂量学影响分析

SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
PubMed 文献 · Radiother Oncol · 2022-12-19

15例中危前列腺癌患者接受MR-Linac每日自适应SBRT,前列腺40 Gy/5次,GTV同步推量至45 Gy。计划与治疗后扫描显示靶区覆盖可接受,膀胱充盈与GTV及前列腺覆盖降低相关,部分分次中尿道、膀胱、直肠的D0.035 cc约束被超过。

要点

  • 15例中危前列腺癌患者接受MR-Linac每日自适应SBRT,前列腺40 Gy/5次,GTV推量至45 Gy。
  • 膀胱充盈与GTV覆盖降低相关(p=0.03,计划1 vs 2)及前列腺覆盖降低相关(p=0.03,计划2 vs 3)。
  • 验证扫描和治疗后扫描中,尿道D0.035 cc约束超过比例分别为24%和33%,膀胱为31%和45%,直肠为35%和25%。

核心结论

  • MR-Linac引导的每日自适应SBRT联合GTV局灶推量可获得可接受的计划剂量学和实际交付剂量学,自适应计划可能可靠地将处方剂量递送至预定肿瘤靶区。

研究设计与样本

  • 15例经MR检出优势病灶的前列腺癌患者接受MR-Linac每日自适应SBRT,处方40 Gy/5次,GTV推量至45 Gy,于初始计划后采集验证扫描、治疗后采集治疗后扫描,并回顾性勾画调整轮廓、重新计算每日计划以估算实际交付剂量。

主要发现

  • 计划1、2、3的前列腺D95%中位数分别为40.3 Gy、40.5 Gy、40.3 Gy,DIL D95%中位数分别为45.7 Gy、45.2 Gy、44.6 Gy。
  • 膀胱充盈与GTV覆盖降低相关(p=0.03,计划1 vs 2),并与前列腺覆盖降低相关(p=0.03,计划2 vs 3)。
  • 验证扫描和治疗后扫描中,尿道D0.035 cc约束超过比例分别为24%和33%,膀胱分别为31%和45%,直肠分别为35%和25%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Using an magnetic resonance linear accelerator (MR-Linac) may improve the precision of visible tumor boosting with ultra-hypofractionation by accounting for daily positional changes in the target and organs at risk (OAR). PATIENTS AND METHODS: Fifteen patients with prostate cancer and an MR-detected dominant lesion were treated on the MR-Linac with stereotactic body radiation (SBRT) to 40 Gy in 5 fractions, boosting the gross tumor volume (GTV) to 45 Gy with daily adaptive planning. Imaging was acquired again after initial planning (verification scan), and immediately after treatment (post-treatment scan). Prior to beam-on, additional adjustments were made on the verification scan. Contours were retrospectively adjusted on verification and post-treatment scans, and the daily plan recalculated on these scans to estimate the true dose delivered. RESULTS: The median prostate D95% for plan 1, 2 and 3 was 40.3 Gy, 40.5 Gy and 40.3 Gy and DIL D95% was 45.7 Gy, 45.2 Gy and 44.6 Gy, respectively. Bladder filling was associated with reduced GTV coverage (p = 0.03, plan 1 vs 2) and prostate coverage (p = 0.03, plan 2 vs 3). The D0.035 cc constraint was exceeded on verification and post-treatment plans in 24 % and 33 % of fractions for the urethra, 31 % and 45 % for the bladder, and 35 % and 25 % for the rectum, respectively. CONCLUSION: MR-Linac guided, daily adaptive SBRT with focal boosting of the GTV yields acceptable planned and delivered dosimetry. Adaptive planning with a MR-Linac may reliably deliver the prescribed dose to the intended tumor target.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Brennan VS, Burleson S, Kostrzewa C, et al. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes. Radiother Oncol. 2022. PMID: 36549340. doi:10.1016/j.radonc.2022.109441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。